Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Insight Services | PRODUCT CODE: 1916373

Cover Image

PUBLISHER: Global Insight Services | PRODUCT CODE: 1916373

Medical Tourism Market Analysis and Forecast to 2035: Treatment Type, Type, Service Provider, Healthcare Services

PUBLISHED:
PAGES: 705 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4750
PDF & Excel (Site License)
USD 5750
PDF & Excel (Enterprise License)
USD 6750

Add to Cart

Medical Tourism Market is anticipated to expand from $259.0 billion in 2025 to $680.7 billion by 2035, growing at a CAGR of approximately 9.5%. The global medical tourism industry in 2025 is witnessing rapid growth fueled by strategic government initiatives, private sector innovations, and international collaborations. India is emerging as a top destination, with states like Uttar Pradesh, Rajasthan, Telangana, and Assam launching comprehensive policies and investing heavily to boost medical and wellness tourism. Uttar Pradesh offers treatments at 25-30% lower costs compared to metro cities, while Telangana plans to attract ₹15,000 crore in investments, creating over 300,000 jobs by 2030. Rajasthan's "Heal in Rajasthan" initiative aims to upgrade hospitals to international standards and increase global visibility. Assam is set to establish more than 60 medical colleges by 2035, strengthening its healthcare infrastructure.

Private companies like Vaidam Health have expanded services through strategic acquisitions, enhancing patient engagement across Africa and Southeast Asia. MIOT International Hospital in Chennai gained IASIOS accreditation, marking excellence in interventional oncology, and signed MOUs with global medical centers.

Internationally, Turkey continues to lead in hair transplant tourism, attracting over 1.1 million medical tourists in 2024, while South Korea's "Medical Korea" initiative promotes advanced healthcare services globally. Malaysia's government-backed Malaysia Healthcare Travel Council remains a key player, and Thailand maintains its position with 64 accredited hospitals catering to international patients. Notable hospital initiatives include Maharashtra's Mayo Hospital conducting 5,000 free cataract surgeries with corporate funding and Uganda's International Specialized Hospital under public-private partnership set to open in 2025, expected to enhance specialized care in East Africa.

Market Segmentation
TypeDomestic, International
Treatment TypeCardiovascular Treatment, Orthopedic Treatment, Cosmetic Treatment, Cancer Treatment, Dental Treatment, Ophthalmology Treatment, Infertility Treatment, Alternative Medicine, Others (Bariatric Treatment, Wellness Treatment, Neurological Treatment, Knee Transplant)
Service ProvidersPublic, Private
Healthcare ServiceMedical Treatment, Wellness, Alternative Treatment

The top medical tourism destinations in 2025 are India, Turkey, South Korea, Thailand, Malaysia, and Colombia, each recognized for affordability, advanced technology, and high-quality care. This evolving ecosystem positions medical tourism as a booming global sector driven by innovation, investment, and patient-centric services.Mexico stands out for its affordability and proximity to the US, offering medical treatments 30-50% cheaper than in the United States. For example, breast augmentation costs around $3,500 in Mexico versus $8,000 in the US; dental root canals cost $300 compared to $1,500 in the US; and bariatric surgeries are nearly 46% less expensive. These price advantages, combined with short travel times (Mexico is just 2.5-5.3 hours from most US cities), make it a popular choice for American patients.

Average travel times from the US to popular medical tourism destinations vary widely. Mexico is the closest, with flights taking 2.5 to 5.3 hours, making it a convenient choice for many Americans. Costa Rica follows with travel times of 4 to nearly 7 hours. India and Thailand require longer journeys, around 14 to 20 hours and 20 to 22 hours respectively, attracting patients seeking specialized care and cost savings.

In terms of patient volume, over 14 million Americans travel to Canada for medical services annually. Thailand welcomes more than 2.5 million medical tourists each year, India sees around 1.5 million, and Mexico attracts over 1.2 million US citizens. Singapore also draws around 0.5 million foreign patients yearly. These figures reflect the accessibility and appeal of these countries in the global medical tourism market.

Segment Overview

Based on treatment type, the market is segmented into cardiovascular treatment, orthopaedic treatment, cosmetic treatment, cancer treatment, dental treatment, ophthalmology treatment, infertility treatment, alternative medicine, and others. The cosmetic segment is the fastest-growing area within the medical tourism industry, expected to grow at a CAGR of 14.7% from 2025 to 2034. This growth is driven by increasing patient awareness, rising demand for anti-aging treatments, and the high cost of cosmetic implants in developed countries. Awareness of personal care has boosted demand for procedures like body fat reduction and acne treatments. Common surgeries include liposuction, abdominoplasty, breast augmentation, and gluteal augmentation. According to the International Society of Aesthetic Plastic Surgery, around 33.7 million surgical and non-surgical cosmetic procedures were performed worldwide in 2022, up from 30.3 million in 2021, despite a slight decline among plastic surgeons. The surge in global awareness and the steep costs of treatments in developed countries are pushing patients to seek affordable options abroad. India, Singapore, and Thailand have emerged as popular destinations offering world-class cosmetic treatments at significantly lower prices, supported by skilled professionals and advanced technology. Mexico and Latin America are also experiencing growth in cosmetic medical tourism, particularly among U.S. patients. For example, breast augmentation in Mexico can cost around USD 3,000, compared to USD 8,000 in the U.S. The combination of affordable, quality care and attractive travel experiences continues to fuel this expanding market.

Based on service providers, the market is segmented into public and private. The private sector dominates the medical tourism market, holding a 52.0% share in 2024 due to rising global healthcare costs and a large population of uninsured or underinsured patients. Many seek affordable, high-quality care in developing countries where private providers offer advanced technology, skilled professionals, and competitive prices. Leading private hospitals like Apollo Hospitals (India), Bumrungrad International (Thailand), and Mount Elizabeth Hospital (Singapore) have earned global recognition, supported by international accreditations such as JCI. Recent developments in private medical tourism highlight its growth and evolving landscape. In June 2025, Indian facilitator Vaidam Health acquired digital startup MediJourney to expand services in Africa and Southeast Asia, handling over 25,000 patient interactions monthly. In July, Rajasthan launched the "Heal in Rajasthan Policy 2025" to promote medical tourism by combining modern and traditional medicine. Pakistan is developing "The Health Park," a 625-acre medical tourism city near Islamabad under a public-private partnership. Saudi Arabia's "Amaala" wellness project aims to attract luxury medical tourists with world-class resorts. Simultaneously, UK experts have called for stricter regulation of weight loss surgery tourism, especially in countries like Turkey, emphasizing the need for international quality standards to ensure patient safety. These trends underscore the private sector's growing role in delivering safe, affordable, and quality medical tourism services globally.

Geographical Overview

The Asia Pacific region led the medical tourism market in 2024 with a 42.0% share, driven by advanced healthcare infrastructure, technological innovation, and strong government support. Thailand and India are key contributors, attracting millions of international patients annually due to their combination of quality care and affordable prices. Thailand's Bumrungrad International Hospital offers procedures like hip replacement at around USD 18,151 nearly half the cost in the U.S. India blends modern medicine with traditional healing through its AYUSH system, covering Ayurveda, Yoga, Unani, Siddha, and Homeopathy. The Indian government has boosted this sector by improving AYUSH infrastructure, launching global awareness campaigns, and introducing the AYUSH mark to certify traditional therapies. Endorsements from the WHO and US FDA further enhance India's reputation. In recent developments, October 2024 saw TransNusa partner with Sunway Medical Centre and Asia OneHealthcare, expanding healthcare options for travelers. Additionally, in January 2024, Parexel collaborated with the Japanese Foundation for Cancer Research to improve access to oncology clinical trials in Japan, opening new opportunities for cancer patients.

The Middle East and Africa region is the fastest-growing medical tourism market, expected to expand at a CAGR of 13.3% from 2025 to 2034. This growth is driven by substantial investments in healthcare infrastructure and government initiatives promoting medical and wellness tourism. In March 2024, the Egyptian government began developing a comprehensive plan to transform several unique locations into medical tourism destinations, aiming to attract more international patients. Countries like the UAE and Saudi Arabia are also rapidly enhancing their medical facilities, with projects such as Saudi Arabia's luxury "Amaala" wellness resort targeting high-end medical tourists. The UAE has become a regional hub offering advanced treatments in cardiology, oncology, and cosmetic surgery through internationally accredited private hospitals. Increased healthcare standards, strategic partnerships with global medical institutions, and growing awareness are positioning the Middle East as a competitive and attractive destination for medical tourism.

Key Trends and Drivers

Cost Advantage in Developing Countries Fuels Growth of Medical Tourism -

Developing countries are experiencing growth in medical tourism due to their much lower treatment costs compared to developed nations. Factors such as lower labor expenses, simplified regulations, and reduced operational costs help keep healthcare affordable in these regions. For example, cancer treatment in countries like India and Turkey typically costs between $7,000 and $11,000, while similar procedures in the United States can exceed $100,000. This cost advantage is driving the expansion of medical tourism markets in developing countries and supporting their economic growth.

Rising Senior Medical Tourism -

Every year, around 14 million people travel internationally for medical care, with seniors forming an increasingly significant segment. In the U.S. and Canada, seniors represent over 17% and 19% of the population respectively, many of whom are retirees seeking affordable healthcare combined with lifestyle benefits. Popular destinations like Costa Rica, Panama, Mexico, and Cuba attract these travelers with cost-effective living, quality medical services, and visa incentives. With the global senior population expected to rise sharply by 2030, demand for senior-focused medical tourism services is set to expand rapidly.

Research Scope

  • Estimates and forecasts the overall market size across Treatment Type, Type, Service Provider, Healthcare Services, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements. Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.
Product Code: GIS21988

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Treatment Type
  • 2.2 Key Market Highlights by Service Providers
  • 2.3 Key Market Highlights by Type
  • 2.4 Key Market Highlights by Healthcare Service

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Treatment Type (2020-2035)
    • 4.1.1 Cardiovascular Treatment
    • 4.1.2 Orthopedic Treatment
    • 4.1.3 Cosmetic Treatment
    • 4.1.4 Cancer Treatment
    • 4.1.5 Dental Treatment
    • 4.1.6 Ophthalmology Treatment
    • 4.1.7 Infertility Treatment
    • 4.1.8 Alternative Medicine
    • 4.1.9 Others (Bariatric Treatment, Wellness Treatment, Neurological Treatment, Knee Transplant)
  • 4.2 Market Size & Forecast by Service Providers (2020-2035)
    • 4.2.1 Public
    • 4.2.2 Private
  • 4.3 Market Size & Forecast by Type (2020-2035)
    • 4.3.1 Domestic
    • 4.3.2 International
  • 4.4 Market Size & Forecast by Healthcare Service (2020-2035)
    • 4.4.1 Medical Treatment
    • 4.4.2 Wellness
    • 4.4.3 Alternative Treatment5 Regional Analysis
  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Treatment Type
      • 5.2.1.2 Service Providers
      • 5.2.1.3 Type
      • 5.2.1.4 Healthcare Service
    • 5.2.2 Canada
      • 5.2.2.1 Treatment Type
      • 5.2.2.2 Service Providers
      • 5.2.2.3 Type
      • 5.2.2.4 Healthcare Service
    • 5.2.3 Mexico
      • 5.2.3.1 Treatment Type
      • 5.2.3.2 Service Providers
      • 5.2.3.3 Type
      • 5.2.3.4 Healthcare Service
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Treatment Type
      • 5.3.1.2 Service Providers
      • 5.3.1.3 Type
      • 5.3.1.4 Healthcare Service
    • 5.3.2 Argentina
      • 5.3.2.1 Treatment Type
      • 5.3.2.2 Service Providers
      • 5.3.2.3 Type
      • 5.3.2.4 Healthcare Service
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Treatment Type
      • 5.3.3.2 Service Providers
      • 5.3.3.3 Type
      • 5.3.3.4 Healthcare Service
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Treatment Type
      • 5.4.1.2 Service Providers
      • 5.4.1.3 Type
      • 5.4.1.4 Healthcare Service
    • 5.4.2 India
      • 5.4.2.1 Treatment Type
      • 5.4.2.2 Service Providers
      • 5.4.2.3 Type
      • 5.4.2.4 Healthcare Service
    • 5.4.3 South Korea
      • 5.4.3.1 Treatment Type
      • 5.4.3.2 Service Providers
      • 5.4.3.3 Type
      • 5.4.3.4 Healthcare Service
    • 5.4.4 Japan
      • 5.4.4.1 Treatment Type
      • 5.4.4.2 Service Providers
      • 5.4.4.3 Type
      • 5.4.4.4 Healthcare Service
    • 5.4.5 Australia
      • 5.4.5.1 Treatment Type
      • 5.4.5.2 Service Providers
      • 5.4.5.3 Type
      • 5.4.5.4 Healthcare Service
    • 5.4.6 Taiwan
      • 5.4.6.1 Treatment Type
      • 5.4.6.2 Service Providers
      • 5.4.6.3 Type
      • 5.4.6.4 Healthcare Service
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Treatment Type
      • 5.4.7.2 Service Providers
      • 5.4.7.3 Type
      • 5.4.7.4 Healthcare Service
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Treatment Type
      • 5.5.1.2 Service Providers
      • 5.5.1.3 Type
      • 5.5.1.4 Healthcare Service
    • 5.5.2 France
      • 5.5.2.1 Treatment Type
      • 5.5.2.2 Service Providers
      • 5.5.2.3 Type
      • 5.5.2.4 Healthcare Service
    • 5.5.3 United Kingdom
      • 5.5.3.1 Treatment Type
      • 5.5.3.2 Service Providers
      • 5.5.3.3 Type
      • 5.5.3.4 Healthcare Service
    • 5.5.4 Spain
      • 5.5.4.1 Treatment Type
      • 5.5.4.2 Service Providers
      • 5.5.4.3 Type
      • 5.5.4.4 Healthcare Service
    • 5.5.5 Italy
      • 5.5.5.1 Treatment Type
      • 5.5.5.2 Service Providers
      • 5.5.5.3 Type
      • 5.5.5.4 Healthcare Service
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Treatment Type
      • 5.5.6.2 Service Providers
      • 5.5.6.3 Type
      • 5.5.6.4 Healthcare Service
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Treatment Type
      • 5.6.1.2 Service Providers
      • 5.6.1.3 Type
      • 5.6.1.4 Healthcare Service
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Treatment Type
      • 5.6.2.2 Service Providers
      • 5.6.2.3 Type
      • 5.6.2.4 Healthcare Service
    • 5.6.3 South Africa
      • 5.6.3.1 Treatment Type
      • 5.6.3.2 Service Providers
      • 5.6.3.3 Type
      • 5.6.3.4 Healthcare Service
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Treatment Type
      • 5.6.4.2 Service Providers
      • 5.6.4.3 Type
      • 5.6.4.4 Healthcare Service
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Treatment Type
      • 5.6.5.2 Service Providers
      • 5.6.5.3 Type
      • 5.6.5.4 Healthcare Service6 Market Strategy
  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Apollo Hospitals Enterprise
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bumrungrad International Hospital
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Bangkok Hospital
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Fortis Healthcare
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 KPJ Healthcare
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Raffles Medical Group
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Prince Court Medical Centre
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Gleneagles Hospital
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Mount Elizabeth Hospital
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Wockhardt Hospitals
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Seoul National University Hospital
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Samitivej Hospital
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Mediclinic International
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Acibadem Healthcare Group
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 IHH Healthcare
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Anadolu Medical Center
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Clemenceau Medical Center
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Medicana International Istanbul
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Vejthani Hospital
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Yashoda Hospitals
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis
  • 8.21 Med Voyage International
    • 8.21.1 Overview
    • 8.21.2 Product Summary
    • 8.21.3 Financial Performance
    • 8.21.4 SWOT Analysis
  • 8.22 Health Link Travel
    • 8.22.1 Overview
    • 8.22.2 Product Summary
    • 8.22.3 Financial Performance
    • 8.22.4 SWOT Analysis
  • 8.23 Wellness Abroad
    • 8.23.1 Overview
    • 8.23.2 Product Summary
    • 8.23.3 Financial Performance
    • 8.23.4 SWOT Analysis
  • 8.24 Care Quest Global
    • 8.24.1 Overview
    • 8.24.2 Product Summary
    • 8.24.3 Financial Performance
    • 8.24.4 SWOT Analysis
  • 8.25 Medi Pathway
    • 8.25.1 Overview
    • 8.25.2 Product Summary
    • 8.25.3 Financial Performance
    • 8.25.4 SWOT Analysis
  • 8.26 Cure Cross
    • 8.26.1 Overview
    • 8.26.2 Product Summary
    • 8.26.3 Financial Performance
    • 8.26.4 SWOT Analysis
  • 8.27 Global Health Partners
    • 8.27.1 Overview
    • 8.27.2 Product Summary
    • 8.27.3 Financial Performance
    • 8.27.4 SWOT Analysis
  • 8.28 Vita Medica Journeys
    • 8.28.1 Overview
    • 8.28.2 Product Summary
    • 8.28.3 Financial Performance
    • 8.28.4 SWOT Analysis
  • 8.29 Health Bridge Travel
    • 8.29.1 Overview
    • 8.29.2 Product Summary
    • 8.29.3 Financial Performance
    • 8.29.4 SWOT Analysis
  • 8.30 Med Excellence
    • 8.30.1 Overview
    • 8.30.2 Product Summary
    • 8.30.3 Financial Performance
    • 8.30.4 SWOT Analysis
  • 8.31 Well Care Travel
    • 8.31.1 Overview
    • 8.31.2 Product Summary
    • 8.31.3 Financial Performance
    • 8.31.4 SWOT Analysis
  • 8.32 Bio Tourism Solutions
    • 8.32.1 Overview
    • 8.32.2 Product Summary
    • 8.32.3 Financial Performance
    • 8.32.4 SWOT Analysis
  • 8.33 Transcend Health
    • 8.33.1 Overview
    • 8.33.2 Product Summary
    • 8.33.3 Financial Performance
    • 8.33.4 SWOT Analysis
  • 8.34 Med Journeys International
    • 8.34.1 Overview
    • 8.34.2 Product Summary
    • 8.34.3 Financial Performance
    • 8.34.4 SWOT Analysis
  • 8.35 Health Pioneer Travel
    • 8.35.1 Overview
    • 8.35.2 Product Summary
    • 8.35.3 Financial Performance
    • 8.35.4 SWOT Analysis
  • 8.36 Cura World
    • 8.36.1 Overview
    • 8.36.2 Product Summary
    • 8.36.3 Financial Performance
    • 8.36.4 SWOT Analysis
  • 8.37 Medi Globe Travels
    • 8.37.1 Overview
    • 8.37.2 Product Summary
    • 8.37.3 Financial Performance
    • 8.37.4 SWOT Analysis
  • 8.38 Wellness Way
    • 8.38.1 Overview
    • 8.38.2 Product Summary
    • 8.38.3 Financial Performance
    • 8.38.4 SWOT Analysis
  • 8.39 Care Connect International
    • 8.39.1 Overview
    • 8.39.2 Product Summary
    • 8.39.3 Financial Performance
    • 8.39.4 SWOT Analysis
  • 8.40 Med Venture Hub
    • 8.40.1 Overview
    • 8.40.2 Product Summary
    • 8.40.3 Financial Performance
    • 8.40.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!